Michael Weiser's Insider Trades & SAST Disclosures

Michael Weiser's most recent trade in Iovance Biotherapeutics Inc was a trade of 67,546 Deferred Restricted Stock Unit done . Disclosure was reported to the exchange on June 13, 2025.

Share

Note

This is a custom search result for pattern Michael Weiser.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Iovance Biotherapeutics Inc	Michael Weiser	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2025	67,546	67,546	-		-	Deferred Restricted Stock Unit
Iovance Biotherapeutics Inc	Michael Weiser	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	49,303	49,303	-		-	Deferred Restricted Stock Unit
Iovance Biotherapeutics Inc	Michael Weiser	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2024	100,000	100,000	-		-	Deferred Restricted Stock Unit
Iovance Biotherapeutics Inc	Michael Weiser	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2023	51,955	51,955	-		-	Deferred Restricted Stock Unit
Iovance Biotherapeutics Inc	Michael Weiser	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2022	51,204	51,204	-		-	Deferred Restricted Stock Unit
Iovance Biotherapeutics Inc	Michael Weiser	Director	Purchase of securities on an exchange or from another person at price $ 6.80 per share.	31 May 2022	7,813	112,632 (0%)	0%	6.8	53,128	Common Stock
Iovance Biotherapeutics Inc	Michael Weiser	Director	Purchase of securities on an exchange or from another person at price $ 6.79 per share.	31 May 2022	2,187	104,819 (0%)	0%	6.8	14,850	Common Stock
Iovance Biotherapeutics Inc	Michael Weiser	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jun 2021	35,000	35,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades